AVAI (Avai Bio) Buyback Yield %: -1.19 (As of Jun. 29, 2026)


AVAI Avai Bio Inc AVAI
24 GF Score
Price $0.15
! 3 Warning Signs
View Full Analysis

What is Avai Bio Buyback Yield %?

Avai Bio AVAI -3.77% 24 Buyback Yield % is -1.19 as of Jun. 29, 2026. GuruFocus rates AVAI with a GF Score™ of 24/100. The stock has 3 warning signs investors should review. Among 1,301 Software companies, Avai Bio ranks worse than 61.95% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Avai Bio's current buyback yield was -1.19%.

Avai Bio Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Avai Bio's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avai Bio Buyback Yield % Chart

Avai Bio Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Buyback Yield %
Get a 7-Day Free Trial 0.00 0.00 -0.21 -1.10 -1.58

Avai Bio Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.48 -1.58 -1.17 -0.46 -0.50

AVAI vs IPM, RCT, LPSN: Buyback Yield % Comparison

For the Software - Application subindustry, Avai Bio's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avai Bio Buyback Yield % vs Software Industry

For the Software industry and Technology sector, Avai Bio's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Avai Bio's Buyback Yield % falls into.


AVAI
24GF Score
Avai Bio Inc AVAI
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avai Bio Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Avai Bio's Buyback Yield for the fiscal year that ended in Mar. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 1.044) / 65.93472
=-1.58%

Avai Bio's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0.264) / 52.45216
=-0.50%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -1.19 mean?
Avai Bio (AVAI) has a Buyback Yield % of -1.19 as of Jun. 29, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Avai Bio and its competitors. According to the industry distribution chart, Avai Bio ranks #806 out of 1301 companies in the Software industry, placing it in the top 62%.
Is Avai Bio's Buyback Yield % too high?
Avai Bio's current Buyback Yield % is -1.19. Based on the distribution chart, Avai Bio ranks #806 out of 1301 companies in the Software industry, which is below the industry midpoint. Overall, Avai Bio has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Avai Bio's Buyback Yield % compare to IPM and RCT?
According to the Software industry distribution chart, Avai Bio ranks #806 out of 1301 companies for Buyback Yield %. This places Avai Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Software company?
A good Buyback Yield % depends on the Software industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Avai Bio and its competitors. Avai Bio's current Buyback Yield % is -1.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avai Bio stock overvalued right now?
Avai Bio (AVAI) has a current Buyback Yield % of -1.19. The current Buyback Yield % is -1.19. Avai Bio's overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Avai Bio (AVAI), the current Buyback Yield % is -1.19 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avai Bio Business Description

Address 5348 Vegas Drive, Las Vegas, NV, USA, 89108
Avai Bio Inc is a biotechnology company focused on identifying genetically modified cell lines, and through joint venture and licensing agreements, developing cell-based therapies. The company has two development programs in its cellular therapies pipeline, a diabetes development program to advance a treatment for type 1 and type 2 insulin-dependent diabetes, and an ?-Klotho protein development program to advance therapies for age-related diseases and anti-aging treatments.
24GF Score

Get the complete analysis for AVAI

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price